Civic Intelligence

The Naspghan Foundation

990 • Fiscal year 2014 • EIN 76-0585072

Jan 01, 2014 to Dec 31, 2014 • Filed on Nov 11, 2015

Organization ProfileWWW.NASPGHAN.ORG/WMSPAGE.CFM?PARM1=635
714 N Bethlehem Pike No 300Ambler, PA 19002

(215) 233-0808

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

63rd percentile

0.23x

Higher debt load relative to assets than 63% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2014

Liabilities / Revenue

80th percentile

0.68x

Higher debt load relative to revenue than 80% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2014

Net Margin

61st percentile

6.9%

Higher net margin than 61% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2014

Top Officer Pay

84th percentile

$148,820

Higher top officer pay than 84% of similar nonprofits.

Top officer pay equals 10.6% of source-year revenue.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2014

Asset Growth

46th percentile

1.0%

Faster asset growth than 46% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2013 to 2014

Revenue Growth

44th percentile

1.7%

Faster revenue growth than 44% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2013 to 2014

Balance Sheet
Liabilities / Assets63rd percentile

Assets

Up

$4,108,702

Up $41,370 (+1.0%) from 2013

Net Assets

Up

$3,153,916

Up $75,446 (+2.5%) from 2013

Liabilities

Down

$954,786

Down $34,076 (-3.4%) from 2013

Revenue And Expenses
Liabilities / Revenue80th percentileNet Margin61st percentile

Revenue

Up

$1,408,074

Up $23,352 (+1.7%) from 2013

Expenses

Up

$1,310,503

Up $60,189 (+4.8%) from 2013

Net Income

Down

$97,571

Down $36,837 (-27%) from 2013

Historical Trend

Balance Sheet Trend

Asset Growth46th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2010: $4,217,937Liabilities 2010: $1,304,144Net Assets 2010: $2,913,7932010Assets 2011: $3,872,828Liabilities 2011: $993,448Net Assets 2011: $2,879,3802011Assets 2012: $4,314,002Liabilities 2012: $1,417,338Net Assets 2012: $2,896,6642012Assets 2013: $4,067,332Liabilities 2013: $988,862Net Assets 2013: $3,078,4702013Assets 2014: $4,108,702Liabilities 2014: $954,786Net Assets 2014: $3,153,9162014Assets 2015: $4,293,861Liabilities 2015: $1,186,791Net Assets 2015: $3,107,0702015Assets 2016: $4,561,907Liabilities 2016: $1,235,592Net Assets 2016: $3,326,3152016Assets 2017: $4,421,521Liabilities 2017: $1,013,676Net Assets 2017: $3,407,8452017Assets 2018: $4,502,389Liabilities 2018: $1,237,472Net Assets 2018: $3,264,9172018Assets 2019: $4,869,576Liabilities 2019: $950,580Net Assets 2019: $3,918,9962019Assets 2020: $5,610,869Liabilities 2020: $1,052,211Net Assets 2020: $4,558,6582020Assets 2021: $6,522,780Liabilities 2021: $1,200,434Net Assets 2021: $5,322,3462021Assets 2022: $6,677,645Liabilities 2022: $1,431,689Net Assets 2022: $5,245,9562022Assets 2023: $7,458,927Liabilities 2023: $1,785,821Net Assets 2023: $5,673,1062023Assets 2024: $8,213,426Liabilities 2024: $1,756,363Net Assets 2024: $6,457,0632024

Highlighted filing

2014

Assets$4,108,702
Liabilities$954,786
Net Assets$3,153,916
Open 2014 Filing

Operations Trend

Revenue Growth44th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MExpenses 2010: $1,529,0712010Revenue 2011: $1,107,751Expenses 2011: $1,112,855Net Income 2011: -$5,1042011Expenses 2012: $1,239,4352012Revenue 2013: $1,384,722Expenses 2013: $1,250,314Net Income 2013: $134,4082013Revenue 2014: $1,408,074Expenses 2014: $1,310,503Net Income 2014: $97,5712014Revenue 2015: $1,196,576Expenses 2015: $1,104,860Net Income 2015: $91,7162015Revenue 2016: $1,469,708Expenses 2016: $1,321,081Net Income 2016: $148,6272016Revenue 2017: $1,069,272Expenses 2017: $1,183,802Net Income 2017: -$114,5302017Revenue 2018: $1,261,701Expenses 2018: $1,178,150Net Income 2018: $83,5512018Revenue 2019: $1,594,603Expenses 2019: $1,307,252Net Income 2019: $287,3512019Revenue 2020: $1,544,768Expenses 2020: $1,085,923Net Income 2020: $458,8452020Revenue 2021: $1,880,637Expenses 2021: $1,235,543Net Income 2021: $645,0942021Revenue 2022: $1,995,391Expenses 2022: $1,511,688Net Income 2022: $483,7032022Revenue 2023: $1,825,546Expenses 2023: $1,721,379Net Income 2023: $104,1672023Revenue 2024: $2,269,887Expenses 2024: $1,855,146Net Income 2024: $414,7412024

Highlighted filing

2014

Revenue$1,408,074
Expenses$1,310,503
Net Income$97,571
Open 2014 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
Nov 11, 2015
Return Version
2014v5.0
Gross Receipts
$1,914,501
Mission and Program Overview

Mission

See schedule o statement[1] to fund and promote research and educational programs that will advance the creation, application, and dissemination of knowledge of gastrointestinal, hepatobiliary, pancreatic and nutritional disorders in children.[2] to identify, encourage, support, and coordinate scientific research and professional study of these pediatric disorders.[3] to strengthen the role of pediatric gastrointestinal and nutritional scientists as leaders in research and education in these medical and health care fields.[4] to evaluate and improve the quality and availability of medical care for children with digestive disorders.[5] to support the research and educational programs of its parent organization (north american society for pediatric gastroenterology hepatology and nutrition inc.)

Research/education in children's gastrointestinal, hepatobiliary, pancreatic & nutritional disorders.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$2,889,666$3,005,027▲ $115,361
Savings and Temporary Cash Investments$735,325$642,506▼ $92,819
Pledges and Grants Receivable$330,000$248,071▼ $81,929
Cash and Non-Interest-Bearing Accounts$112,127$208,097▲ $95,970
Prepaid Expenses and Deferred Charges$214$5,001▲ $4,787
Total Assets$4,067,332$4,108,702▲ $41,370
Liabilities
Grants Payable$802,500$872,000▲ $69,500
Deferred Revenue$170,790$58,949▼ $111,841
Accounts Payable and Accrued Expenses$5,179$23,837▲ $18,658
Other Liabilities$10,393$0▼ $10,393
Total Liabilities$988,862$954,786▼ $34,076
Net Assets / Fund Balance
Permanently Rstr Net Assets$2,500,000$2,500,000→ $0
Unrestricted Net Assets$361,987$385,630▲ $23,643
Temporarily Rstr Net Assets$216,483$268,286▲ $51,803
Total Net Assets Fund Balance$3,078,470$3,153,916▲ $75,446
Total Liabilities and Net Assets / Fund Balance$4,067,332$4,108,702▲ $41,370

Endowment Activity

PeriodBeginningContrib.Gain/LossOther UsesEnd
2014$2,500,000---$2,500,000
2013$2,500,000---$2,500,000
2012$2,500,000---$2,500,000
2011$2,500,000---$2,500,000
2010$2,500,000---$2,500,000
Compensation and Service Providers
Top Officer Pay84th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Margaret StallingsExecutive DirectorPT$50,000$98,820$148,820

Board Members and Trustees

NameTitle
William BalistreriPast President
John BarnardPresident
Ann ScheimannDirector
Athos BousvarosDirector
Carlo Di LorenzoDirector
Jeannie HuangDirector
Leo HeitlingerDirector
Michael NarkewiczDirector
Nicola JonesDirector
Barry WershilSecretary-treasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Amy AmenelaProject Consulting8204 LAKEHEATH WAY, Potomac, MD 20854$157,550
Revenue and Support

Revenue Composition

Contributions and Grants
$1,281,421
Program Service Revenue
$0
Investment Income
$126,653
Other Revenue
$0
All Other Contributions
$1,131,421
Change in Net Assets
$97,571

Audited Revenue Reconciliation

Revenue per Audited Statements
$1,311,088
Revenue Not Reported on Financial Statements
$96,986
Revenue Not Reported on Form 990
$-22,125
Other Revenue Adjustments
$75,000
Total Revenue per Audited Statements
$1,288,963
Total Revenue per Form 990
$1,408,074
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$805,712
Other Expenses$454,791
Total Fundraising Expense$151,633
Salaries, Compensation, and Employee Benefits$50,000
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Individuals$800,712--$800,712
Fees for Services Other$13,783-$138,987$152,770
Current Officers, Directors, Trustees, and Key Employees$35,000$10,000$5,000$50,000
Fees for Service Investment Mgmnt Fees-$21,986-$21,986
Travel$8,764$2,504$1,252$12,520
All Other Expenses$389$8,706$3,036$12,131
Grants to Domestic Orgs$5,000--$5,000
Occupancy$3,465$990$495$4,950
Other Expenses$3,592$4,410$2,205$3,592
Office Expenses$2,510$716$359$3,585
Insurance$2,093$598$299$2,990
Information Technology-$1,159-$1,159
Total Functional Expenses$1,107,801$51,069$151,633$1,310,503

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Form 990$1,310,503
Expenses per Audited Statements$1,213,517
Total Expenses per Audited Statements$1,213,517
Expenses Not Reported on Financial Statements$96,986
Other Expense Adjustments$75,000
Expenses Not Reported on Form 990$0
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11

“Governing body review of form 990 prior to its filing with the irs, a copy of the form 990 is reviewed by board of directors either electronically or at annual board meeting.”

Form 990, Part VI, Section B, Line 12C

“Monitoring and enforcement of conflicts policy disclosure updated on an annual basis via "disclosure website". Updated and confirmed at all meetings/conference calls.”

Form 990, Part VI, Section B, Line 15

“Process for determining compensation the process for determining compensation for executive director includes the following: [1] review of similar societies; and [2] annual evaluation”

Form 990, Part VI, Section C, Line 19

“Public availability of other documents they are available upon request and for inspection at the organization's office.”

Filing and Contact Details

Filer

Filer Name
The Naspghan Foundation
EIN
76-0585072
Phone
2152330808
Address
714 N BETHLEHEM PIKE NO 300, AMBLER, PA 19002

Signing Officer

Name
Margaret Stallings
Title
Executive Director
Phone
2152330808
Signed
2015-11-11
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Barry Wershil
Formed
1988
Legal Domicile
TX
Voting Board Members
10
Independent Board Members
10
Employees
0
Volunteers
50

Preparer

Firm
Bbd Llp
Address
1835 MARKET STREET 26TH FLOOR, PHILADELPHIA, PA 19103
Preparer
Jennifer Solot
Phone
2155677770
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Campaign and fundraising consultant: program service expenses 0. Management and general expenses 0. Fundraising expenses 101,220. Total expenses 101,220. Grant review: program service expenses 13,783. Management and general expenses 0. Fundraising expenses 0. Total expenses 13,783. Others: program service expenses 0. Management and general expenses 0. Fundraising expenses 37,767. Total expenses 37,767.”

SCHEDULE R, PART II, COLUMN B, NASPGHAN'S PRIMARY ACTIVITY:

“The mission of the north american society for pediatric gastroenterology, hepatology and nutrition is to advance the understanding of normal development, physiology and pathophysiology of diseases of the gastrointestinal tract and liver in children, improve quality of care by fostering the dissemination of this knowledge through scientific meetings, professional and public education, and policy development, and serve as an effective voice for members and the profession.”

Financial Statement Notes

PART V, LINE 4:

“Intended use of the endowment funds it consists of two endowments, all of which were received from pharmaceutical companies. The investment income for each endowment fund is restricted for the following purposes: [1]the investment income from $1,500,000 is restricted for innovative research awards. [2]the investment income from $1,000,000 is restricted for research grants in acid-peptic disorders.”

PART X, LINE 2:

“Uncertain tax positions under asc 740 the foundation has adopted an accounting standard regarding uncertain tax positions. The standard prescribes a minimum threshold that a tax position is required to meet in order to be recognized in the financial statements. The foundation believes that it had no uncertain tax positions as defined in the standard and, as a result, the adoption of the standard has had no impact on the foundation's financial statements. The foundation files federal and pennsylvania tax returns and, generally, is not subject to tax examinations for years prior to 2011.”

PART XI, LINE 4B - OTHER ADJUSTMENTS:

“Grant cancellation 75,000.”

PART XII, LINE 4B - OTHER ADJUSTMENTS:

“RE-GRANT 75,000.”

Raw XML AppendixShowing 400 of 544 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt05179
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt023837
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0RESEARCH/EDUCATION IN CHILDREN'S GASTROINTESTINAL, HEPATOBILIARY, PANCREATIC & NUTRITIONAL DISORDERS.
IRS990/AddressChangeInd0X
IRS990/AllOtherContributionsAmt01131421
IRS990/AllOtherExpensesGrp/FundraisingAmt03036
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt08706
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0389
IRS990/AllOtherExpensesGrp/TotalAmt012131
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0EXECUTIVE DIRECTOR
IRS990/BooksInCareOfDetail/PhoneNum02152330808
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt01501 BETHLEHEM PIKE
IRS990/BooksInCareOfDetail/USAddress/CityNm0FLOURTOWN
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019031
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0112127
IRS990/CashNonInterestBearingGrp/EOYAmt0208097
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt01
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt05000
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt010000
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt035000
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt050000
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt0157550
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt08204 LAKEHEATH WAY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0POTOMAC
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd020854
IRS990/ContractorCompensationGrp/ContractorName/PersonNm0AMY AMENELA
IRS990/ContractorCompensationGrp/ServicesDesc0PROJECT CONSULTING
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01281421
IRS990/CYGrantsAndSimilarPaidAmt0805712
IRS990/CYInvestmentIncomeAmt0126653
IRS990/CYOtherExpensesAmt0454791
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt097571
IRS990/CYSalariesCompEmpBnftPaidAmt050000
IRS990/CYTotalExpensesAmt01310503
IRS990/CYTotalFundraisingExpenseAmt0151633
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01408074
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt0170790
IRS990/DeferredRevenueGrp/EOYAmt058949
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0GRANTS AND AWARDS:[1] NASPGHAN/NASPGHAN FOUNDATION GEORGE FERRY YOUNG INVESTIGATOR DEVELOPMENT AWARD:- THIS TWO-YEAR GRANT IS AVAILABLE TO NEW AND JUNIOR FACULTY TO SUPPORT RESEARCH ACTIVITIES THAT HAVE THE POTENTIAL FOR EVOLUTION TO AN INDEPENDENT RESEARCH CAREER IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY OR NUTRITION. MONIES ARE AWARDED IN SUPPORT OF A MERITORIOUS RESEARCH PROJECT IN THE CLINICAL OR BASIC SCIENCES TO STUDY THE GASTROINTESTINAL TRACT, LIVER OR PANCREAS IN CHILDREN.SEE SCHEDULE O FOR CONTINUATIONS[2] NASPGHAN FOUNDATION/NESTLE NUTRITION RESEARCH YOUNG INVESTIGATOR DEVELOPMENT AWARD:- THIS TWO-YEAR GRANT IS AVAILABLE TO NEW AND JUNIOR FACULTY TO SUPPORT RESEARCH ACTIVITIES THAT HAVE THE POTENTIAL FOR EVOLUTION TO AN INDEPENDENT RESEARCH CAREER IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY OR NUTRITION. THIS GRANT, SUPPORTED BY NESTLE NUTRITION INSTITUTE, IS AWARDED TO SUPPORT MERITORIOUS BASIC OR CLINICAL PROPOSAL RELATING TO NUTRITION IN INFANCY, CHILDHOOD OR ADOLESCENCE.[3] NASPGHAN FOUNDATION/CROHN'S & COLITIS FOUNDATION OF AMERICA YOUNG INVESTIGATOR DEVELOPMENT AWARD:- THIS TWO-YEAR GRANT, FUNDED IN CONJUNCTION WITH THE CROHN'S & COLITIS FOUNDATION OF AMERICA, IS AVAILABLE TO NEW AND JUNIOR FACULTY IN SUPPORT OF RESEARCH RELATING TO A CLINICAL, EPIDEMIOLOGICAL OR A BASIC SCIENTIFIC ASPECT OF PEDIATRIC CROHN'S DISEASE AND/OR ULCERATIVE COLITIS.[4] NASPGHAN FOUNDATION FELLOW TO FACULTY TRANSITION AWARD IN INFLAMMATORY BOWEL DISEASES:- THIS AWARD PROVIDES SUPPORT TO ENABLE PROMISING SENIOR PEDIATRIC GASTROENTEROLOGY FELLOWS TO SPEND AN ADDITIONAL YEAR UPON COMPLETION OF THEIR FELLOWSHIP TRAINING ENGAGED IN FULL-TIME RESEARCH AND PATIENT CARE RELATED TO PEDIATRIC INFLAMMATORY BOWEL DISEASES (IBD). THE INTENT OF THIS RESEARCH AWARD IS TO DEVELOP ADDITIONAL CLINICAL AND RESEARCH EXPERTISE IN PEDIATRIC IBD.[5] NASPGHAN FOUNDATION/TAKEDA PHARMACEUTICALS NORTH AMERICA INC RESEARCH INNOVATION AWARD:- IT PROVIDES A TWO-YEAR GRANT FOR INNOVATIVE, HIGH-IMPACT RESEARCH IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION. THE INTENT OF THIS RESEARCH AWARD IS TO STIMULATE SCIENTIFIC INQUIRY IN AN AREA THAT IS EXCEPTIONALLY INNOVATIVE AND HAS THE POTENTIAL TO IMPACT THE FIELD IN A HIGHLY NOVEL MANNER. APPLICANTS AT ANY CAREER LEVEL MAY APPLY.[6] NASPGHAN FOUNDATION/ASTRAZENECA RESEARCH IN PEPTIC ULCER DISEASES:- THIS AWARD IS GRANTED TO AN INVESTIGATOR TO STUDY THE EPIDEMIOLOGY, PATHOGENESIS, NATURAL HISTORY, GENETICS, DIAGNOSIS AND MANAGEMENT OF PEPTIC DISEASES AFFECTING CHILDREN. "PEPTIC DISEASES" REFERS TO A VARIETY OF DISORDERS INCLUDING, BUT NOT LIMITED TO, GASTROESOPHAGEAL REFLUX, REFLUX ESOPHAGITIS, EOSINOPHILIC (ALLERGIC) ESOPHAGITIS, MOTILITY DISORDERS OF THE UPPER GASTROINTESTINAL TRACT, HELICOBACTER PYLORI INFECTION WITH OR WITHOUT ULCERATION, NON-ULCER DYSPEPSIA, AND NON-BACTERIAL ULCER DISEASES.[7] NASPGHAN FOUNDATION IN-OFFICE MEMBER GRANT FOR DEVELOPMENT OF PATIENT EDUCATION PROTOTYPES: THE ONE-YEAR GRANTS SUPPORT DEVELOPMENT AND IMPLEMENTATION OF PROTOTYPE PROJECTS WHICH FOCUS ON PATIENT EDUCATION IN PRACTICE SETTINGS. THE GOAL OF THIS GRASSROOTS PROGRAM IS TO SUPPORT PATIENTS' NEEDS THROUGH PROTOTYPIC CONCEPTS THAT COULD POTENTIALLY BE UTILIZED BY THE NASPGHAN/APGNN COMMUNITY IN THE FUTURE.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0842306
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesOtherGrp/FundraisingAmt0138987
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt013783
IRS990/FeesForServicesOtherGrp/TotalAmt0152770
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt021986
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt021986
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt03.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt136.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt32.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt107.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/PersonNm0JOHN BARNARD
IRS990/Form990PartVIISectionAGrp/PersonNm1WILLIAM BALISTRERI
IRS990/Form990PartVIISectionAGrp/PersonNm2BARRY WERSHIL
IRS990/Form990PartVIISectionAGrp/PersonNm3ATHOS BOUSVAROS
IRS990/Form990PartVIISectionAGrp/PersonNm4CARLO DI LORENZO
IRS990/Form990PartVIISectionAGrp/PersonNm5LEO HEITLINGER
IRS990/Form990PartVIISectionAGrp/PersonNm6JEANNIE HUANG
IRS990/Form990PartVIISectionAGrp/PersonNm7NICOLA JONES
IRS990/Form990PartVIISectionAGrp/PersonNm8MICHAEL NARKEWICZ
IRS990/Form990PartVIISectionAGrp/PersonNm9ANN SCHEIMANN
IRS990/Form990PartVIISectionAGrp/PersonNm10MARGARET STALLINGS
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1050000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt1098820
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1PAST PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY-TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10EXECUTIVE DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01988
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolAndSepBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt027790
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt010
IRS990/GrantAmt0805712
IRS990/GrantsPayableGrp/BOYAmt0802500
IRS990/GrantsPayableGrp/EOYAmt0872000
IRS990/GrantsToDomesticIndividualsGrp/ProgramServicesAmt0800712
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt0800712
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt05000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt05000
IRS990/GrantsToIndividualsInd01
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt0534217
IRS990/GrossReceiptsAmt01914501
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt010
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt01159
IRS990/InformationTechnologyGrp/TotalAmt01159
IRS990/InsuranceGrp/FundraisingAmt0299
IRS990/InsuranceGrp/ManagementAndGeneralAmt0598
IRS990/InsuranceGrp/ProgramServicesAmt02093
IRS990/InsuranceGrp/TotalAmt02990
IRS990/InvestmentIncomeGrp/ExclusionAmt098863
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt098863
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt02889666
IRS990/InvestmentsPubTradedSecGrp/EOYAmt03005027
IRS990/IRPDocumentCnt011
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0TX
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt0506427
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0SEE SCHEDULE O STATEMENT[1] TO FUND AND PROMOTE RESEARCH AND EDUCATIONAL PROGRAMS THAT WILL ADVANCE THE CREATION, APPLICATION, AND DISSEMINATION OF KNOWLEDGE OF GASTROINTESTINAL, HEPATOBILIARY, PANCREATIC AND NUTRITIONAL DISORDERS IN CHILDREN.[2] TO IDENTIFY, ENCOURAGE, SUPPORT, AND COORDINATE SCIENTIFIC RESEARCH AND PROFESSIONAL STUDY OF THESE PEDIATRIC DISORDERS.[3] TO STRENGTHEN THE ROLE OF PEDIATRIC GASTROINTESTINAL AND NUTRITIONAL SCIENTISTS AS LEADERS IN RESEARCH AND EDUCATION IN THESE MEDICAL AND HEALTH CARE FIELDS.[4] TO EVALUATE AND IMPROVE THE QUALITY AND AVAILABILITY OF MEDICAL CARE FOR CHILDREN WITH DIGESTIVE DISORDERS.[5] TO SUPPORT THE RESEARCH AND EDUCATIONAL PROGRAMS OF ITS PARENT ORGANIZATION (NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY HEPATOLOGY AND NUTRITION INC.)
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt03078470
IRS990/NetAssetsOrFundBalancesEOYAmt03153916
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt027790
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt027790
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0-22125
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt0495
IRS990/OccupancyGrp/ManagementAndGeneralAmt0990
IRS990/OccupancyGrp/ProgramServicesAmt03465
IRS990/OccupancyGrp/TotalAmt04950
IRS990/OfficeExpensesGrp/FundraisingAmt0359
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0716
IRS990/OfficeExpensesGrp/ProgramServicesAmt02510
IRS990/OfficeExpensesGrp/TotalAmt03585
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0EDUCATION MATERIALS
IRS990/OtherExpensesGrp/Desc1PROFESSIONAL FEES
IRS990/OtherExpensesGrp/Desc2GRANT EXPENSES
IRS990/OtherExpensesGrp/FundraisingAmt02205
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt04410
IRS990/OtherExpensesGrp/ProgramServicesAmt0217058
IRS990/OtherExpensesGrp/ProgramServicesAmt115435
IRS990/OtherExpensesGrp/ProgramServicesAmt23592
IRS990/OtherExpensesGrp/TotalAmt0217058
IRS990/OtherExpensesGrp/TotalAmt122050
IRS990/OtherExpensesGrp/TotalAmt23592
IRS990/OtherLiabilitiesGrp/BOYAmt010393
IRS990/OtherLiabilitiesGrp/EOYAmt00
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PermanentlyRstrNetAssetsGrp/BOYAmt02500000
IRS990/PermanentlyRstrNetAssetsGrp/EOYAmt02500000
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0330000
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0248071
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0214
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt05001
IRS990/PrincipalOfficerNm0BARRY WERSHIL
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0EDUCATIONAL CAMPAIGNS:IBD NEWSLETTER SERIES FOR MEDICAL PROFESSIONALS- IMPROVING HEALTH SUPERVISION OF CHILDREN AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE (IBD). - UTILIZE APPROPRIATE SCREENING TOOLS FOR THE ACCURATE DIAGNOSIS OF IBD IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS IN THE PRIMARY CARE SETTING. - INITIATE AND/OR MONITOR RECOMMENDED PHARMACOTHERAPY. - SCREEN AND DIAGNOSE IBD PATIENTS SUFFERING FROM COMORBID DEPRESSION. SEE SCHEDULE O FOR CONTINUATIONS - DEVELOP COLLABORATIVE CARE PLANS WITH PRIMARY AND SUBSPECIALTY PROVIDERS IN EFFORTS TO PROVIDE APPROPRIATE PHARMACOTHERAPY AND SOCIAL SUPPORT FOR PATIENTS WITH IBD AND THEIR FAMILIES.- IMPROVING THE TRANSITION PROCESS - IDENTIFY THE NEEDS OF IBD PATIENTS FOR A SUCCESSFUL TRANSITION FROM PEDIATRIC TO ONGOING ADULT CARE. - EXPLORE POTENTIAL BARRIERS TO THIS TRANSITION FROM THE PERSPECTIVES OF PATIENTS, FAMILIES, AND MEDICAL TEAM MEMBERS. - UTILIZE THE CHECKLIST AND PATIENT WEB RESOURCE TO DEVELOP AN EFFECTIVE TRANSITION PLAN FOR PEDIATRIC IBD PATIENTS, WITH A FOCUS ON DEVELOPING PATIENT INDEPENDENCE, EDUCATION, AND COMMUNICATION. - INCORPORATE PARENTS AND FAMILY MEMBERS OF PEDIATRIC IBD PATIENTS INTO THE PLANNING PROCESS TO ENSURE THEIR SUPPORT. - DEVELOP A TEAM APPROACH (WHEN AVAILABLE) IN TRANSITIONING IBD PATIENTS FROM PEDIATRIC CARE TO ADULT CARE, AND UTILIZE AVAILABLE TRANSITION RESOURCES.- MONITORING DISEASE ACTIVITYIDENTIFY VALIDATED INDICES TO EVALUATE DISEASE PROGRESSION, SEVERITY OF DISEASE, AND EFFICACY OF PHARMACOTHERAPIES FOR CHILDREN WITH IBD. - UTILIZE APPROPRIATE INDICES FOR CHILDREN WITH UC AND CD BASED ON THEIR PRESENTING SYMPTOMS. - IMPLEMENT INDICES TO MONITOR DISEASE ACTIVITY IN APPROPRIATE CHILDREN WITH IBD WHILE UNDERSTANDING THE ADVANTAGES AND DISADVANTAGES OF EACH TOOL.- MAKING THE RIGHT DIAGNOSISRENDER ACCURATE DIAGNOSES BASED ON IDENTIFYING THE RANGE OF HISTOLOGICAL FEATURES AND ENDOSCOPIC FINDINGS OF PEDIATRIC UC AND CD. - DIFFERENTIATE PEDIATRIC IBD FROM ASLC. - APPLY CONSISTENT CLASSIFICATION AND DIAGNOSTIC CRITERIA TO MORE ACCURATELY PHENOTYPE PEDIATRIC IBD PATIENTS. - IMPLEMENT A SYSTEMATIC APPROACH TO DIAGNOSIS AND MANAGEMENT BASED UPON A STANDARD ALGORITHM. - DELINEATE THE FEATURES OF IBD-UNCLASSIFIED AND HOW TO FOLLOW UP THESE CASES.- CAPSULE ENDOSCOPYCAPPY COMIC BOOK AND PARENT HAND OUT FOCUSING ON EDUCATING THE PATIENT AND FAMILY ABOUT WHAT IS A CAPSULE ENDOSCOPY AND HOW IS THE PROCEDURE IMPLEMENTED.- CME COURSE "NASPGHAN NUTRITION UNIVERSITY"THIS COURSE IS DESIGNED TO PROVIDE SPECIALIZED NUTRITION EDUCATION IN AREAS ASSOCIATED WITH THE PRACTICE OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION FOR 3RD YEAR POSTDOCTORAL FELLOWS AND GRADUATES OF PEDIATRIC GASTROENTEROLOGY TRAINING PROGRAMS (GRADUATED WITHIN THE LAST 10 YEARS). THE COURSE INCLUDED A FACULTY DEBATE FOLLOWED BY A SERIES OF SMALL GROUP HANDS-ON CASE-BASED LEARNING OF SEVERAL CHALLENGING CASES ON SATURDAY.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0265495
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01281467
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0692985
IRS990/PYInvestmentIncomeAmt0103255
IRS990/PYOtherExpensesAmt0507329
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0134408
IRS990/PYSalariesCompEmpBnftPaidAmt050000
IRS990/PYTotalExpensesAmt01250314
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01384722
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt097571
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt0150000
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0735325
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0642506
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01281421
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01281467
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0946146
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0932777
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01294127
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt05735938
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt098863
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt095608
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0111720
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt088581
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt083781
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0478553
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt0102027
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus3YearsAmt088250
IRS990ScheduleA/OtherIncome170Grp/TotalAmt0190277
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.53320
IRS990ScheduleA/PublicSupportPY170Pct00.57330
IRS990ScheduleA/PublicSupportTotal170Amt03414871
IRS990ScheduleA/SubstantialContributorsTotAmt02321067
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01281421
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01281467
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0946146
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0932777
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01294127
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt05735938
IRS990ScheduleA/TotalSupportAmt06404768
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/CYEndwmtFundGrp/BeginningYearBalanceAmt02500000
IRS990ScheduleD/CYEndwmtFundGrp/EndYearBalanceAmt02500000
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/BeginningYearBalanceAmt02500000
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/EndYearBalanceAmt02500000
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/BeginningYearBalanceAmt02500000
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/EndYearBalanceAmt02500000
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/BeginningYearBalanceAmt02500000
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/EndYearBalanceAmt02500000
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/BeginningYearBalanceAmt02500000
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/EndYearBalanceAmt02500000
IRS990ScheduleD/EndowmentsHeldRelatedOrgInd00
IRS990ScheduleD/EndowmentsHeldUnrelatedOrgInd00
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt096986
IRS990ScheduleD/ExpensesSubtotalAmt01213517
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt021986
IRS990ScheduleD/InvestmentExpensesNotIncldAmt021986
IRS990ScheduleD/NetUnrealizedGainsInvstAmt0-22125
IRS990ScheduleD/OtherExpensesNotIncludedAmt075000
IRS990ScheduleD/OtherRevenuesNotIncludedAmt075000
IRS990ScheduleD/PrmnntEndowmentBalanceEOYPct01.00000
IRS990ScheduleD/RevenueNotReportedAmt0-22125
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt096986
IRS990ScheduleD/RevenueSubtotalAmt01311088
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0INTENDED USE OF THE ENDOWMENT FUNDS IT CONSISTS OF TWO ENDOWMENTS, ALL OF WHICH WERE RECEIVED FROM PHARMACEUTICAL COMPANIES. THE INVESTMENT INCOME FOR EACH ENDOWMENT FUND IS RESTRICTED FOR THE FOLLOWING PURPOSES: [1]THE INVESTMENT INCOME FROM $1,500,000 IS RESTRICTED FOR INNOVATIVE RESEARCH AWARDS. [2]THE INVESTMENT INCOME FROM $1,000,000 IS RESTRICTED FOR RESEARCH GRANTS IN ACID-PEPTIC DISORDERS.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt1UNCERTAIN TAX POSITIONS UNDER ASC 740 THE FOUNDATION HAS ADOPTED AN ACCOUNTING STANDARD REGARDING UNCERTAIN TAX POSITIONS. THE STANDARD PRESCRIBES A MINIMUM THRESHOLD THAT A TAX POSITION IS REQUIRED TO MEET IN ORDER TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS. THE FOUNDATION BELIEVES THAT IT HAD NO UNCERTAIN TAX POSITIONS AS DEFINED IN THE STANDARD AND, AS A RESULT, THE ADOPTION OF THE STANDARD HAS HAD NO IMPACT ON THE FOUNDATION'S FINANCIAL STATEMENTS. THE FOUNDATION FILES FEDERAL AND PENNSYLVANIA TAX RETURNS AND, GENERALLY, IS NOT SUBJECT TO TAX EXAMINATIONS FOR YEARS PRIOR TO 2011.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt2GRANT CANCELLATION 75,000.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt3RE-GRANT 75,000.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART V, LINE 4:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc1PART X, LINE 2:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc2PART XI, LINE 4B - OTHER ADJUSTMENTS:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc3PART XII, LINE 4B - OTHER ADJUSTMENTS:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt00
IRS990ScheduleD/TotalExpensesPerForm990Amt01310503
IRS990ScheduleD/TotalRevenuePerForm990Amt01408074
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt01288963
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt01213517
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt0149212
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt1150000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt240000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt3150000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt48000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt5500
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt61000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt72000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt8150000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt9150000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt0CROHN'S & COLITIS FOUNDATION OF AMERICA YOUNG INVESTIGATOR DEVELOPMENT AWARD
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt1YOUNG INVESTIGATOR GRANT
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt2END POINTS GRANT
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt3IBD TRANSITION AWARD
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt4SUMMER STUDENT PROGRAM
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt5TERI LI AWARD
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt6BALISTRERI PRIZE
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt7IN OFFICE GRANT
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt8NESTLE NUTRITION GRANT
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt9PEPTIC ULCER DISEASE
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt00
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt10
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt20
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt30
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt40
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt50
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt60
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt70

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2014 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$4,108,702
Liabilities
$954,786
Net assets
$3,153,916
Revenue
$1,408,074
Expenses
$1,310,503
Net income
$97,571
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$8.21$1.76$6.46$2.27$1.86$0.41
2023Detailed filing. Detailed filing data is available for this year.$7.46$1.79$5.67$1.83$1.72$0.10
2022Detailed filing. Detailed filing data is available for this year.$6.68$1.43$5.25$2.00$1.51$0.48
2021Detailed filing. Detailed filing data is available for this year.$6.52$1.20$5.32$1.88$1.24$0.65
2020Detailed filing. Detailed filing data is available for this year.$5.61$1.05$4.56$1.54$1.09$0.46
2019Detailed filing. Detailed filing data is available for this year.$4.87$0.95$3.92$1.59$1.31$0.29
2018Detailed filing. Detailed filing data is available for this year.$4.50$1.24$3.26$1.26$1.18$0.08
2017Detailed filing. Detailed filing data is available for this year.$4.42$1.01$3.41$1.07$1.18$0.11
2016Detailed filing. Detailed filing data is available for this year.$4.56$1.24$3.33$1.47$1.32$0.15
2015Detailed filing. Detailed filing data is available for this year.$4.29$1.19$3.11$1.20$1.10$0.09
2014Detailed filing. Detailed filing data is available for this year.$4.11$0.95$3.15$1.41$1.31$0.10
2013Detailed filing. Detailed filing data is available for this year.$4.07$0.99$3.08$1.38$1.25$0.13
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$4.31$1.42$2.90$1.24
2011Summary only. Only limited summary data is available for this year.$3.87$0.99$2.88$1.11$1.11$0.01
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$4.22$1.30$2.91$1.53